Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians

by Dr. Rich on December 26, 2011

Conclusions: The increases in diversion and abuse measures indicate the need to take active attempts to curb diversion and abuse as well as continuous monitoring and surveillance of all buprenorphine products. However, these increases parallel the increased number of tablets sold. Finding a balance of risk/benefit (i.e. diversion and abuse versus expanded treatment) remains a challenge. (Source: Drug and Alcohol Dependence)

MedWorm Sponsor Message: Find the best January Sales in the UK.

Previous post:

Next post: